Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer
Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
The present study is a randomized open-label -phase III study that aims to compare the
efficacy and safety of the adjuvant chemotherapy with simultaneous or sequential application
of Zoladex up to 2-3 years for ≤ 45 year old premenopausal hormone receptor-positive breast
cancer.